Global Pharmaceutical Quality Control Market

Pharmaceutical Quality Control Comprehensive Study by Products (Consumables, Instruments, Services), End Users (Hospitals/Clinics, Laboratories, Ambulatory Surgical Centres), Analysis Type (Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Leachable Testing, Raw Material Testing, Pharmaceutical Microbiology, Endotoxin testing, Package testing, Pharma gas testing, Others), Products Tested (Vaccines, Plasma Product, Drugs) Players and Region - Global Market Outlook to 2027

Pharmaceutical Quality Control Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Pharmaceutical Quality Control Market Scope
Quality control is an essential operation of the pharmaceutical industry. Drugs must be marketed as safe and therapeutically active formulations whose performance is consistent and predictable. New and better medicinal agents are being produced at an accelerated rate. A significant portion of the CGMP regulations (21 CFR 211) pertains to the quality control laboratory and product testing. Drugs are critical to human health and well-being, so their quality is critical. The primary concern in the pharmaceutical industry is patient safety. The pharmaceutical industry is one of the most heavily regulated industries in the world, And to protect the reputation of the company. Testing raw materials, in-process products, and finished products, only products of the highest quality are released for sale. Growing adoption of digital technology and automation this factor is driving the market and Additional costs involved in quality control and budget constraints in hospitals this factor may restrain the market.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledSotera Health Co (United States), BioMerieux SA (France), SGS S.A. (Switzerland), Charles River Laboratories International Inc. (United States), WiXi AppTec (China), Merck KGaA (Germany), Intertek (United Kingdom), APTYS PHARMACEUTICALS (France), Thermo Fisher Scientific Inc. (United States) and Toxikon Corporation (United States)
CAGR%


Competition among existing players is due to the stiff market share occupied by leading players. The industry leader is engaged in offering innovative and superior-quality products to cater to the ever-growing demand for automation in the industry. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Pharmaceutical Quality Control market throughout the predicted period.

Sotera Health Co (United States), BioMerieux SA (France), SGS S.A. (Switzerland), Charles River Laboratories International Inc. (United States), WiXi AppTec (China), Merck KGaA (Germany), Intertek (United Kingdom), APTYS PHARMACEUTICALS (France), Thermo Fisher Scientific Inc. (United States) and Toxikon Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Novovitae (United States), Sartorius AG (Germany), REMI Group (India), Perkin Elmer (United States), National Quality Control laboratory (Kenya), Lucideon Limited (United States), ALTEN Group (France), Zahrawi Group (Dubai) and InphA (Italy).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Pharmaceutical Quality Control market by Type and Region with country level break-up.

On the basis of geography, the market of Pharmaceutical Quality Control has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.

Market Leaders and their expansionary development strategies
SGS Announces the Acquisition of Quay Pharmaceuticals Limited. Quay Pharmaceuticals Limited (Quay Pharma), is a UK-based provider of innovative, formulation research and development services for the global biopharmaceutical sector.
In December 2022, Labcorp, a leading global life sciences company, announced that they larger anatomic pathology and histology (APH) laboratory in Los Angeles, expanding the company’s global central laboratory capabilities.


Influencing Trend:
Increase safety, awareness, and Precaution after the covid-19 pandemic

Market Growth Drivers:
Growing adoption of digital technology and automation

Challenges:
Lack of effective quality management system

Restraints:
Additional costs involved in quality control and budget constraints in hospitals

Opportunities:
Technological advancements in pharma quality control laboratory

Key Target Audience
Pharma Manufacturers, suppliers, Governments regulatory, Industry Experts, End Users and Others

Report Objectives / Segmentation Covered

By Products
  • Consumables
  • Instruments
  • Services

By End Users
  • Hospitals/Clinics
  • Laboratories
  • Ambulatory Surgical Centres

By Analysis Type
  • Sterility Testing
  • Bioburden Testing
  • Endotoxin Testing
  • Stability Testing
  • Leachable Testing
  • Raw Material Testing
  • Pharmaceutical Microbiology
  • Endotoxin testing
  • Package testing
  • Pharma gas testing
  • Others

By Products Tested
  • Vaccines
  • Plasma Product
  • Drugs

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing adoption of digital technology and automation
    • 3.3. Market Challenges
      • 3.3.1. Lack of effective quality management system
    • 3.4. Market Trends
      • 3.4.1. Increase safety, awareness, and Precaution after the covid-19 pandemic
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmaceutical Quality Control, by Products, End Users, Analysis Type, Products Tested and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Pharmaceutical Quality Control (Value)
      • 5.2.1. Global Pharmaceutical Quality Control by: Products (Value)
        • 5.2.1.1. Consumables
        • 5.2.1.2. Instruments
        • 5.2.1.3. Services
      • 5.2.2. Global Pharmaceutical Quality Control by: End Users (Value)
        • 5.2.2.1. Hospitals/Clinics
        • 5.2.2.2. Laboratories
        • 5.2.2.3. Ambulatory Surgical Centres
      • 5.2.3. Global Pharmaceutical Quality Control by: Analysis Type (Value)
        • 5.2.3.1. Sterility Testing
        • 5.2.3.2. Bioburden Testing
        • 5.2.3.3. Endotoxin Testing
        • 5.2.3.4. Stability Testing
        • 5.2.3.5. Leachable Testing
        • 5.2.3.6. Raw Material Testing
        • 5.2.3.7. Pharmaceutical Microbiology
        • 5.2.3.8. Endotoxin testing
        • 5.2.3.9. Package testing
        • 5.2.3.10. Pharma gas testing
        • 5.2.3.11. Others
      • 5.2.4. Global Pharmaceutical Quality Control by: Products Tested (Value)
        • 5.2.4.1. Vaccines
        • 5.2.4.2. Plasma Product
        • 5.2.4.3. Drugs
      • 5.2.5. Global Pharmaceutical Quality Control Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Pharmaceutical Quality Control: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sotera Health Co (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BioMerieux SA (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. SGS S.A. (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Charles River Laboratories International Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. WiXi AppTec (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck KGaA (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Intertek (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. APTYS PHARMACEUTICALS (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Thermo Fisher Scientific Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Toxikon Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pharmaceutical Quality Control Sale, by Products, End Users, Analysis Type, Products Tested and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Pharmaceutical Quality Control (Value)
      • 7.2.1. Global Pharmaceutical Quality Control by: Products (Value)
        • 7.2.1.1. Consumables
        • 7.2.1.2. Instruments
        • 7.2.1.3. Services
      • 7.2.2. Global Pharmaceutical Quality Control by: End Users (Value)
        • 7.2.2.1. Hospitals/Clinics
        • 7.2.2.2. Laboratories
        • 7.2.2.3. Ambulatory Surgical Centres
      • 7.2.3. Global Pharmaceutical Quality Control by: Analysis Type (Value)
        • 7.2.3.1. Sterility Testing
        • 7.2.3.2. Bioburden Testing
        • 7.2.3.3. Endotoxin Testing
        • 7.2.3.4. Stability Testing
        • 7.2.3.5. Leachable Testing
        • 7.2.3.6. Raw Material Testing
        • 7.2.3.7. Pharmaceutical Microbiology
        • 7.2.3.8. Endotoxin testing
        • 7.2.3.9. Package testing
        • 7.2.3.10. Pharma gas testing
        • 7.2.3.11. Others
      • 7.2.4. Global Pharmaceutical Quality Control by: Products Tested (Value)
        • 7.2.4.1. Vaccines
        • 7.2.4.2. Plasma Product
        • 7.2.4.3. Drugs
      • 7.2.5. Global Pharmaceutical Quality Control Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmaceutical Quality Control: by Products(USD Million)
  • Table 2. Pharmaceutical Quality Control Consumables , by Region USD Million (2016-2021)
  • Table 3. Pharmaceutical Quality Control Instruments , by Region USD Million (2016-2021)
  • Table 4. Pharmaceutical Quality Control Services , by Region USD Million (2016-2021)
  • Table 5. Pharmaceutical Quality Control: by End Users(USD Million)
  • Table 6. Pharmaceutical Quality Control Hospitals/Clinics , by Region USD Million (2016-2021)
  • Table 7. Pharmaceutical Quality Control Laboratories , by Region USD Million (2016-2021)
  • Table 8. Pharmaceutical Quality Control Ambulatory Surgical Centres , by Region USD Million (2016-2021)
  • Table 9. Pharmaceutical Quality Control: by Analysis Type(USD Million)
  • Table 10. Pharmaceutical Quality Control Sterility Testing , by Region USD Million (2016-2021)
  • Table 11. Pharmaceutical Quality Control Bioburden Testing , by Region USD Million (2016-2021)
  • Table 12. Pharmaceutical Quality Control Endotoxin Testing , by Region USD Million (2016-2021)
  • Table 13. Pharmaceutical Quality Control Stability Testing , by Region USD Million (2016-2021)
  • Table 14. Pharmaceutical Quality Control Leachable Testing , by Region USD Million (2016-2021)
  • Table 15. Pharmaceutical Quality Control Raw Material Testing , by Region USD Million (2016-2021)
  • Table 16. Pharmaceutical Quality Control Pharmaceutical Microbiology , by Region USD Million (2016-2021)
  • Table 17. Pharmaceutical Quality Control Endotoxin testing , by Region USD Million (2016-2021)
  • Table 18. Pharmaceutical Quality Control Package testing , by Region USD Million (2016-2021)
  • Table 19. Pharmaceutical Quality Control Pharma gas testing , by Region USD Million (2016-2021)
  • Table 20. Pharmaceutical Quality Control Others , by Region USD Million (2016-2021)
  • Table 21. Pharmaceutical Quality Control: by Products Tested(USD Million)
  • Table 22. Pharmaceutical Quality Control Vaccines , by Region USD Million (2016-2021)
  • Table 23. Pharmaceutical Quality Control Plasma Product , by Region USD Million (2016-2021)
  • Table 24. Pharmaceutical Quality Control Drugs , by Region USD Million (2016-2021)
  • Table 25. South America Pharmaceutical Quality Control, by Country USD Million (2016-2021)
  • Table 26. South America Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 27. South America Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 28. South America Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 29. South America Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 30. Brazil Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 31. Brazil Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 32. Brazil Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 33. Brazil Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 34. Argentina Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 35. Argentina Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 36. Argentina Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 37. Argentina Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 38. Rest of South America Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 39. Rest of South America Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 40. Rest of South America Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 41. Rest of South America Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 42. Asia Pacific Pharmaceutical Quality Control, by Country USD Million (2016-2021)
  • Table 43. Asia Pacific Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 44. Asia Pacific Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 45. Asia Pacific Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 46. Asia Pacific Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 47. China Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 48. China Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 49. China Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 50. China Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 51. Japan Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 52. Japan Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 53. Japan Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 54. Japan Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 55. India Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 56. India Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 57. India Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 58. India Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 59. South Korea Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 60. South Korea Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 61. South Korea Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 62. South Korea Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 63. Australia Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 64. Australia Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 65. Australia Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 66. Australia Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 67. Rest of Asia-Pacific Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 68. Rest of Asia-Pacific Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 69. Rest of Asia-Pacific Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 70. Rest of Asia-Pacific Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 71. Europe Pharmaceutical Quality Control, by Country USD Million (2016-2021)
  • Table 72. Europe Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 73. Europe Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 74. Europe Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 75. Europe Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 76. Germany Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 77. Germany Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 78. Germany Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 79. Germany Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 80. France Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 81. France Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 82. France Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 83. France Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 84. Italy Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 85. Italy Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 86. Italy Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 87. Italy Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 88. United Kingdom Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 89. United Kingdom Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 90. United Kingdom Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 91. United Kingdom Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 92. Netherlands Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 93. Netherlands Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 94. Netherlands Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 95. Netherlands Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 96. Rest of Europe Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 97. Rest of Europe Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 98. Rest of Europe Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 99. Rest of Europe Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 100. MEA Pharmaceutical Quality Control, by Country USD Million (2016-2021)
  • Table 101. MEA Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 102. MEA Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 103. MEA Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 104. MEA Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 105. Middle East Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 106. Middle East Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 107. Middle East Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 108. Middle East Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 109. Africa Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 110. Africa Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 111. Africa Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 112. Africa Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 113. North America Pharmaceutical Quality Control, by Country USD Million (2016-2021)
  • Table 114. North America Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 115. North America Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 116. North America Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 117. North America Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 118. United States Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 119. United States Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 120. United States Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 121. United States Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 122. Canada Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 123. Canada Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 124. Canada Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 125. Canada Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 126. Mexico Pharmaceutical Quality Control, by Products USD Million (2016-2021)
  • Table 127. Mexico Pharmaceutical Quality Control, by End Users USD Million (2016-2021)
  • Table 128. Mexico Pharmaceutical Quality Control, by Analysis Type USD Million (2016-2021)
  • Table 129. Mexico Pharmaceutical Quality Control, by Products Tested USD Million (2016-2021)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Pharmaceutical Quality Control: by Products(USD Million)
  • Table 141. Pharmaceutical Quality Control Consumables , by Region USD Million (2022-2027)
  • Table 142. Pharmaceutical Quality Control Instruments , by Region USD Million (2022-2027)
  • Table 143. Pharmaceutical Quality Control Services , by Region USD Million (2022-2027)
  • Table 144. Pharmaceutical Quality Control: by End Users(USD Million)
  • Table 145. Pharmaceutical Quality Control Hospitals/Clinics , by Region USD Million (2022-2027)
  • Table 146. Pharmaceutical Quality Control Laboratories , by Region USD Million (2022-2027)
  • Table 147. Pharmaceutical Quality Control Ambulatory Surgical Centres , by Region USD Million (2022-2027)
  • Table 148. Pharmaceutical Quality Control: by Analysis Type(USD Million)
  • Table 149. Pharmaceutical Quality Control Sterility Testing , by Region USD Million (2022-2027)
  • Table 150. Pharmaceutical Quality Control Bioburden Testing , by Region USD Million (2022-2027)
  • Table 151. Pharmaceutical Quality Control Endotoxin Testing , by Region USD Million (2022-2027)
  • Table 152. Pharmaceutical Quality Control Stability Testing , by Region USD Million (2022-2027)
  • Table 153. Pharmaceutical Quality Control Leachable Testing , by Region USD Million (2022-2027)
  • Table 154. Pharmaceutical Quality Control Raw Material Testing , by Region USD Million (2022-2027)
  • Table 155. Pharmaceutical Quality Control Pharmaceutical Microbiology , by Region USD Million (2022-2027)
  • Table 156. Pharmaceutical Quality Control Endotoxin testing , by Region USD Million (2022-2027)
  • Table 157. Pharmaceutical Quality Control Package testing , by Region USD Million (2022-2027)
  • Table 158. Pharmaceutical Quality Control Pharma gas testing , by Region USD Million (2022-2027)
  • Table 159. Pharmaceutical Quality Control Others , by Region USD Million (2022-2027)
  • Table 160. Pharmaceutical Quality Control: by Products Tested(USD Million)
  • Table 161. Pharmaceutical Quality Control Vaccines , by Region USD Million (2022-2027)
  • Table 162. Pharmaceutical Quality Control Plasma Product , by Region USD Million (2022-2027)
  • Table 163. Pharmaceutical Quality Control Drugs , by Region USD Million (2022-2027)
  • Table 164. South America Pharmaceutical Quality Control, by Country USD Million (2022-2027)
  • Table 165. South America Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 166. South America Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 167. South America Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 168. South America Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 169. Brazil Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 170. Brazil Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 171. Brazil Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 172. Brazil Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 173. Argentina Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 174. Argentina Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 175. Argentina Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 176. Argentina Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 177. Rest of South America Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 178. Rest of South America Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 179. Rest of South America Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 180. Rest of South America Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 181. Asia Pacific Pharmaceutical Quality Control, by Country USD Million (2022-2027)
  • Table 182. Asia Pacific Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 183. Asia Pacific Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 184. Asia Pacific Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 185. Asia Pacific Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 186. China Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 187. China Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 188. China Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 189. China Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 190. Japan Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 191. Japan Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 192. Japan Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 193. Japan Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 194. India Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 195. India Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 196. India Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 197. India Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 198. South Korea Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 199. South Korea Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 200. South Korea Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 201. South Korea Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 202. Australia Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 203. Australia Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 204. Australia Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 205. Australia Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 206. Rest of Asia-Pacific Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 207. Rest of Asia-Pacific Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 208. Rest of Asia-Pacific Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 209. Rest of Asia-Pacific Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 210. Europe Pharmaceutical Quality Control, by Country USD Million (2022-2027)
  • Table 211. Europe Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 212. Europe Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 213. Europe Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 214. Europe Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 215. Germany Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 216. Germany Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 217. Germany Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 218. Germany Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 219. France Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 220. France Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 221. France Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 222. France Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 223. Italy Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 224. Italy Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 225. Italy Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 226. Italy Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 227. United Kingdom Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 228. United Kingdom Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 229. United Kingdom Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 230. United Kingdom Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 231. Netherlands Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 232. Netherlands Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 233. Netherlands Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 234. Netherlands Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 235. Rest of Europe Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 236. Rest of Europe Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 237. Rest of Europe Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 238. Rest of Europe Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 239. MEA Pharmaceutical Quality Control, by Country USD Million (2022-2027)
  • Table 240. MEA Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 241. MEA Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 242. MEA Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 243. MEA Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 244. Middle East Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 245. Middle East Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 246. Middle East Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 247. Middle East Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 248. Africa Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 249. Africa Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 250. Africa Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 251. Africa Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 252. North America Pharmaceutical Quality Control, by Country USD Million (2022-2027)
  • Table 253. North America Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 254. North America Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 255. North America Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 256. North America Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 257. United States Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 258. United States Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 259. United States Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 260. United States Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 261. Canada Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 262. Canada Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 263. Canada Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 264. Canada Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 265. Mexico Pharmaceutical Quality Control, by Products USD Million (2022-2027)
  • Table 266. Mexico Pharmaceutical Quality Control, by End Users USD Million (2022-2027)
  • Table 267. Mexico Pharmaceutical Quality Control, by Analysis Type USD Million (2022-2027)
  • Table 268. Mexico Pharmaceutical Quality Control, by Products Tested USD Million (2022-2027)
  • Table 269. Research Programs/Design for This Report
  • Table 270. Key Data Information from Secondary Sources
  • Table 271. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmaceutical Quality Control: by Products USD Million (2016-2021)
  • Figure 5. Global Pharmaceutical Quality Control: by End Users USD Million (2016-2021)
  • Figure 6. Global Pharmaceutical Quality Control: by Analysis Type USD Million (2016-2021)
  • Figure 7. Global Pharmaceutical Quality Control: by Products Tested USD Million (2016-2021)
  • Figure 8. South America Pharmaceutical Quality Control Share (%), by Country
  • Figure 9. Asia Pacific Pharmaceutical Quality Control Share (%), by Country
  • Figure 10. Europe Pharmaceutical Quality Control Share (%), by Country
  • Figure 11. MEA Pharmaceutical Quality Control Share (%), by Country
  • Figure 12. North America Pharmaceutical Quality Control Share (%), by Country
  • Figure 13. Global Pharmaceutical Quality Control share by Players 2021 (%)
  • Figure 14. Global Pharmaceutical Quality Control share by Players (Top 3) 2021(%)
  • Figure 15. Global Pharmaceutical Quality Control share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Sotera Health Co (United States) Revenue, Net Income and Gross profit
  • Figure 18. Sotera Health Co (United States) Revenue: by Geography 2021
  • Figure 19. BioMerieux SA (France) Revenue, Net Income and Gross profit
  • Figure 20. BioMerieux SA (France) Revenue: by Geography 2021
  • Figure 21. SGS S.A. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 22. SGS S.A. (Switzerland) Revenue: by Geography 2021
  • Figure 23. Charles River Laboratories International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Charles River Laboratories International Inc. (United States) Revenue: by Geography 2021
  • Figure 25. WiXi AppTec (China) Revenue, Net Income and Gross profit
  • Figure 26. WiXi AppTec (China) Revenue: by Geography 2021
  • Figure 27. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Merck KGaA (Germany) Revenue: by Geography 2021
  • Figure 29. Intertek (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Intertek (United Kingdom) Revenue: by Geography 2021
  • Figure 31. APTYS PHARMACEUTICALS (France) Revenue, Net Income and Gross profit
  • Figure 32. APTYS PHARMACEUTICALS (France) Revenue: by Geography 2021
  • Figure 33. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2021
  • Figure 35. Toxikon Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Toxikon Corporation (United States) Revenue: by Geography 2021
  • Figure 37. Global Pharmaceutical Quality Control: by Products USD Million (2022-2027)
  • Figure 38. Global Pharmaceutical Quality Control: by End Users USD Million (2022-2027)
  • Figure 39. Global Pharmaceutical Quality Control: by Analysis Type USD Million (2022-2027)
  • Figure 40. Global Pharmaceutical Quality Control: by Products Tested USD Million (2022-2027)
  • Figure 41. South America Pharmaceutical Quality Control Share (%), by Country
  • Figure 42. Asia Pacific Pharmaceutical Quality Control Share (%), by Country
  • Figure 43. Europe Pharmaceutical Quality Control Share (%), by Country
  • Figure 44. MEA Pharmaceutical Quality Control Share (%), by Country
  • Figure 45. North America Pharmaceutical Quality Control Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Sotera Health Co (United States)
  • BioMerieux SA (France)
  • SGS S.A. (Switzerland)
  • Charles River Laboratories International Inc. (United States)
  • WiXi AppTec (China)
  • Merck KGaA (Germany)
  • Intertek (United Kingdom)
  • APTYS PHARMACEUTICALS (France)
  • Thermo Fisher Scientific Inc. (United States)
  • Toxikon Corporation (United States)
Additional players considered in the study are as follows:
Novovitae (United States) , Sartorius AG (Germany) , REMI Group (India) , Perkin Elmer (United States) , National Quality Control laboratory (Kenya) , Lucideon Limited (United States) , ALTEN Group (France) , Zahrawi Group (Dubai) , InphA (Italy)
Select User Access Type

Key Highlights of Report


Jan 2023 221 Pages 62 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pharmaceutical Quality Control Market Quantitative research analysis
Global Pharmaceutical Quality Control Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Pharmaceutical Quality Control Market are by end use application [].
The Pharmaceutical Quality Control Market is gaining popularity and expected to see strong valuation by 2027.
  • Growing adoption of digital technology and automation

Know More About Global Pharmaceutical Quality Control Market Report?

Have a Query? Click Here

Other Related Reports

GMO-free Cosmetic & Personal Care Ingredient Comprehensive Study by Type (OTC Herbal, Traditional Medicine), Application (Pharmacy, Drug Store, Modern Trade, Online, Other OTC Format), (), Form (Liq...
$ 3800
Halal Nutraceuticals Comprehensive Study by Application (Sports Nutrition, General Well-being, Immune Health, Bone Health, Heart Health, Disease Prevention, Weight Loss), Distribution Channel (Pharma...
$ 3800
Kidney Cancer Therapy Comprehensive Study by Drug Type (Branded, Generics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End Use (Hospitals & Clinics, Diagnostic ...
$ 3800
Varicocele Treatment Comprehensive Study by Type (Grade I, Grade II, Grade III, Others), Application (Varicocele Repair, Varicocele Embolization, Others), Distribution Channel (Hospital Pharmacy, Ret...
$ 3800
Vitamin B Comprehensive Study by Type (B1 (Thiamin), B2 (Riboflavin), B3 (Niacin), B5 (Pantothenic Acid), B6 (Pyridoxine), B7 (Biotin), B9 (Folic Acid), B12 (Cobalamin)), Application (Pharmaceutical,...
$ 3800
Biosimilar Contract Manufacturing Comprehensive Study by Type (Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins), Application (Oncology, Blood Disorders, Growth Hormonal Defic...
$ 3800